Parkinson Disease, Secondary (chemically induced) And NotAssunta Imperato
List of bibliographic references
Number of relevant bibliographic references: 10.Ident. | Authors (with country if any) | Title |
---|---|---|
000177 | Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France |
000365 | Dominique Caparros-Lefebvre [France] ; John Steele [États-Unis] ; Yaichiro Kotake [Japon] ; Shigeru Ohta [Japon] | Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: Possible synergy of neurotoxins |
000503 | Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Féger [France] | Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain |
000513 | Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice |
000519 | Imad Ghorayeb [France] ; Pierre O. Fernagut [France] ; Incarnation Aubert [France] ; Erwan Bezard [France] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; François Tison [France] | Toward a primate model of l‐dopa‐unresponsive parkinsonism mimicking striatonigral degeneration |
000528 | Stéphane Palfi [États-Unis] ; Liza Leventhal [États-Unis] ; Christopher G. Goetz [États-Unis] ; Philippe Hantraye [France] ; Ben-Zion Roitberg [États-Unis] ; Joe Sramek [États-Unis] ; Marina Emborg [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Delayed onset of progressive dystonia following subacute 3‐nitropropionic acid treatment in Cebus apella monkeys |
000602 | Abdelhamid Benazzouz [France] ; Thomas Boraud [France] ; Jean Féger [France] ; Pierre Burbaud [France] ; Bernard Bioulac [France] ; Christian Gross [France] | Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment |
000616 | Jean-Louis Montastruc [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; André Rascol [France] | Does fluoxetine aggravate Parkinson's disease? A pilot prospective study |
000630 | Roberto Marconi [France, Italie] ; Dominique Lefebvre-Caparros [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Bruno Dubois [France] ; Agid [France] | Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
000672 | J. A. Temlett [Suisse] ; N. P. Quinn [Royaume-Uni] ; P. G. Jenner [Suisse] ; C. D. Marsden [Royaume-Uni] ; E. Pourcher [France] ; A. Bonnet [France] ; Yves Agid [France] ; R. Markstein [Suisse] ; X. Lataste [Suisse] | Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease |
This area was generated with Dilib version V0.6.23. |